Miscellaneous Studies

• Dose Registry: Dosing Outcomes Study of Erythropoiesis-Stimulating Therapies.
  • EST naïve or been off EST treatment for at least 90 days
  • No end stage renal disease or myelodyplastic syndrome
  • Must be followed up for 16 weeks
  • Can use either Procrit or Aranesp
  • We have 29 patients on this study we need 30.

« back to Clinical Trials list